Literature DB >> 15532806

Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.

Ugur Berberoglu1.   

Abstract

BACKGROUND/AIMS: The presence of lymph node metastases is the main prognostic factor in patients with colorectal cancer. Controversy exits relating to the minimum number of lymph nodes to be harvested for accurate staging in patients classified as stage I and II. The purpose of this study was to define a cut-off value for the number of lymph nodes examined and determine if this minimum number could have any impact on prognosis of node negative patients.
METHODOLOGY: A total of 301 T1-4N0M0 colorectal cancer patients were reviewed. The clinical and pathological factors considered in statistical analysis were age, gender, tumor location, depth of invasion, differentiation and the number of examined lymph nodes.
RESULTS: The median number of harvested lymph nodes was 10 and the 5-year overall survival rate was 62%. Univariate analysis revealed that patients with well differentiated, right-sided, T1-2 tumors and those with more than 11 nodes examined had improved survival compared to their counterparts. In Cox regression analysis, the same variables except tumor location independently affected the prognosis, where the number of lymph nodes recovered showed the highest significance (p=0.0008; RR: 2.8; 95% CI: 1.6-5.2).
CONCLUSIONS: Patients classified as T1-4N0M0 colorectal carcinoma with more than 11 lymph nodes examined may be considered as more accurately staged and have better prognosis than those with lower number of lymph nodes recovered.

Entities:  

Mesh:

Year:  2004        PMID: 15532806

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

1.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

2.  Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance?

Authors:  Catarina Hadamitzky; Hendrik Spohr; Anette S Debertin; Saskia Guddat; Michael Tsokos; Reinhard Pabst
Journal:  J Anat       Date:  2010-03-19       Impact factor: 2.610

3.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

4.  Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer.

Authors:  Pramodh Chitral Chandrasinghe; Dileepa Senajith Ediriweera; Janaki Hewavisenthi; Sumudu Kumarage; Kemal Ismail Deen
Journal:  Indian J Gastroenterol       Date:  2013-09-19

5.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08

6.  Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens.

Authors:  Sebastian G de la Fuente; Roberto J Manson; Kirk A Ludwig; Christopher R Mantyh
Journal:  J Gastrointest Surg       Date:  2008-10-11       Impact factor: 3.452

7.  The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

Review 8.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

9.  Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?

Authors:  Ulrich Güller; Andreas Zettl; Mathias Worni; Igor Langer; Daniela Cabalzar-Wondberg; Carsten T Viehl; Nicolas Demartines; Markus Zuber
Journal:  Cancer       Date:  2012-06-08       Impact factor: 6.860

10.  Quantitative pathology: historical background, clinical research and application of nuclear morphometry and DNA image cytometry.

Authors:  Abdelbaset Buhmeida
Journal:  Libyan J Med       Date:  2006-09-20       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.